Evidence map›Paper›PMID 41754975›Full record

ArticlePharmaceutics2026

Tetronic

Javier Carriles, Carlos Aydillo, Gregory N Smith, Cécile A Dreiss, Paul Nguewa, Gustavo González-Gaitano

Abstract read
In one paragraph

Article in Pharmaceutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Javier CarrilesDepartment of Chemistry, School of Science, University of Navarra, 31080 Pamplona, Spain.
Carlos AydilloDepartment of Pharmaceutical Sciences, Facultad de Farmacia y Nutrición, University of Navarra, 31080 Pamplona, Spain.ORCID 0000-0002-0542-967X
Gregory N SmithISIS Neutron and Muon Source, Science and Technology Facilities Council, Rutherford Appleton Laboratory, Didcot OX11 0QX, UK.ORCID 0000-0002-0074-5657
Cécile A DreissInstitute of Pharmaceutical Science, King's College London, London SE1 9NH, UK.ORCID 0000-0002-0578-8090
Paul NguewaNavarra Institute for Health Research (IdisNA), 31008 Pamplona, Spain.ORCID 0000-0002-2193-7316
Gustavo González-GaitanoDepartment of Chemistry, School of Science, University of Navarra, 31080 Pamplona, Spain.ORCID 0000-0002-1477-6710

Funding

Fundación Roviralta Chair "Maria Francisca de Roviralta of Molecular Parasitology, Leishmaniasis and One Health"Ministerio de Ciencia, Innovación y Universidades MICIU/AEI/10.13039/501100011033, PID2023-147765OB-C21, -C22
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

drug deliverygelsleishmaniasismiltefosinepentamidinepolymeric micellesSANSTetronic

Identifiers

PMID41754975
PMCPMC12944060

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.